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Abstract
Background Takotsubo cardiomyopathy (TTC) is charac-
terised by transient contractility disturbances of the apex of
the left ventricle.
Methods We enrolled 101 patients from the northern-east-
ern part of Poland in the years 2008–2012 who were hos-
pitalised for TCC. The control group consisted of female
patients diagnosed with anterior myocardial infarction with
ST-segment elevation (anterior STEMI) (n = 101).
Results 89 % of the study group were women. Patients
with TTC had diabetes (12.6 % vs 29.7 %; p = 0.002) and
hyperlipidaemia (36.8 % vs 64.4 %; p = 0.0001) signifi-
cantly less frequently, and better kidney function assessed
by estimated glomerular filtration rate versus patients with
anterior STEMI (74.52 % vs 64.30 %; p = 0.004). In the
TTC group there were more patients with chronic obstruc-
tive pulmonary disease (11.6 % vs 1.0 %; p = 0.002) and
thyroid disturbances, especially hyperthyroidism (23.4 % vs
11.0 %; p = 0.021). In patients with TTC sudden cardiac
arrest, pulmonary oedema and cardiogenic shock were ob-
served less frequently than in the control group (14.7 %
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vs 30.7 %; p = 0.0078). Hospitalisations in TTC patients
were less frequently complicated by pneumonia (20.0 % vs
35.6 %; p = 0.0148) and urinary infection (4.2 % vs 21.8 %;
p = 0.0003). Cardiac rupture occurred in 3 patients with
TTC and in 1 with anterior STEMI. In-hospital mortal-
ity was significantly lower in the group with TTC. Also,
mortality at 30 days, 3 months, 1 year and 2.5 years was
significantly lower in patients with TTC than in patients
with MI (p = 0.035; p = 0.0226; p = 0.0075; p = 0.009).
Conclusions Previously considered to be a benign syn-
drome, TTC should be reconsidered as a clinical condi-
tion at risk for serious complications such as cardiac arrest,
cardiogenic shock, pulmonary oedema and cardiac rupture
leading to death and causing substantial early hazard. The
prognosis in TTC is significantly better than in patients with
anterior STEMI.
Keywords Takotsubo cardiomyopathy · Anterior
myocardial infarction
Introduction
Takotsubo cardiomyopathy (TTC), also called ‘apical bal-
looning syndrome’ is a clinical condition, in which there
are transient contractility disturbances of the apex of the
left ventricle and ischaemic changes on the electrocardio-
gram (ECG) without significant luminal narrowing of the
coronary arteries [1–3].
TTC was described for the first time by Sato et al. [1]
in Japan in 1990. The name of the syndrome comes from
a vessel with a narrow upper part and broad bottom used
for catching octopus. This vessel resembles the shape of
the left ventricle, as seen on ventriculography in patients
with ‘apical ballooning syndrome’ [2].
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TTC usually appears in women aged 60–80 years with
several cardiovascular risk factors. The syndrome is usually
provoked by either mental or physical stress, which is why
it is also called ‘stress cardiomyopathy’.
The clinical course of TTC is similar to myocardial in-
farction and accounts for 1 % of all cases of acute coronary
syndromes (ACS). The main symptom is usually chest pain.
In laboratory tests an increased concentration of cardiac
necrotic markers is observed. On ECG ischaemic changes
are recorded [2–6]. TTC usually has a benign clinical
course but some cases can be complicated by cardiogenic
shock, heart failure, dangerous ventricular arrhythmias or
even cardiac rupture and death [7–11].
The aim of the study was to assess the clinical course,
comorbidities, complications, early and late mortality in
a population with TTC as compared with patients with an-
terior myocardial infarction.
Material and methods
In the years 2008–2012, we enrolled 101 patients from the
northern-eastern part of Poland hospitalised due to TTC
in the Department of Cardiology of the University Hospi-
tal in Bialystok and four other cardiology invasive centres
(Department of Invasive Cardiology, Medical University of
Bialystok; Department of Cardiology, ProCardia in Augus-
tow; Department of Cardiology, Provincial Hospital in Bi-
alystok; Department of Cardiology, Provincial Hospital in
Lomza).
Demographic data, cardiovascular risk factors, clinical
course during hospitalisation, results of laboratory tests,
echocardiography and coronary angiography results were
recorded. Only patients with TTC according to the Mayo
Clinic criteria were included in the analysis (all four criteria
must had been fulfilled):
● Transient hypokinesis, akinesis or dyskinesis of the left
ventricular mid segments with or without apical involve-
ment. The regional wall motion abnormalities typically
extend beyond a single epicardial coronary distribution.
A stressful trigger is often but not always present.
● Absence of obstructive coronary disease or angiographic
evidence of acute plaque rupture.
● New electrocardiographic abnormalities (either ST-seg-
ment elevation and/or T-wave inversion) or modest ele-
vation in cardiac troponin.
● Absence of pheochromocytoma or myocarditis. [12]
Five patients were excluded from the analysis, because they
were diagnosed with TTC despite significant narrowing in
the coronary vessels and one patient due to a muscle bridge
in the left anterior descending coronary artery (LAD) with
95 % narrowing during systole.
Obstructive coronary artery disease (CAD) was defined
as a narrowing of ≥50 % of the diameter of the vessel. Non-
obstructive CAD was defined as any narrowing <50 %.
The control group consisted with female patients diag-
nosed with acute anterior myocardial infarction with ST-
segment elevation (anterior STEMI) hospitalised in the De-
partment of Invasive Cardiology, Medical University of Bi-
alystok in the years 2008–2012 (n = 101). The control
group matched the study population regarding age and sex.
Anterior STEMI was diagnosed according to the follow-
ing criteria:
● Clinical symptoms such as chest pain,
● Elevation of cardiac troponin concentration (>0.3 ng/ml),
● ST elevation at the J point in two contiguous ante-
rior leads ( ≥0.1 mV in V1 and V4–V6; ≥0.15 mV in
V2–V3).
The primary endpoint was all-cause mortality in a 2-year
follow-up. All data were obtained from the Polish popu-
lation registry in Bialystok (Podlasie Province Office) or
by telephone contact with the patients. The study protocol
conformed with the ethical guidelines of the 1975 Decla-
ration of Helsinki, and was approved by the local ethics
committee (no R-I-002/26/2013).
Statistical analysis
Distribution of each variable was tested with the Kol-
mogorov-Smirnov test. Afterwards the Student’s t test or
the Mann-Whitney U test were used for statistical analy-
sis where applicable. Additional analysis of correlations
between non-categorical variables was performed using
Pearson or Spearman tests, where applicable. Survival
rates were displayed with Kaplan-Meier curves. Multi-
variate logistic regression was used to test associations
between variables and outcomes. Data are expressed as
means and standard deviations. Relative frequencies are
used to present categorical variables. These variables were
assessed by the χ2 test. A p value of less than 0.05 was con-
sidered to be statistically significant. The statistic software
NCSS 2010 was used.
Results
Demographic characteristics of the population are shown
in Table. 1; 89 % of the study group were women. Pa-
tients with TTC had diabetes (12.6 % vs 29.7 %; p = 0.002)
and hyperlipidaemia (36.8 % vs 64.4 %; p = 0.0001) signifi-
cantly less frequently, and a better kidney function assessed
by estimated glomerular filtration rate (eGFR) as compared
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Table 1 Clinical characteristics, concomitant diseases, clinical course and complications
TTC
n = 95 (SD)
Anterior STEMI
n = 101 (SD)
p
Clinical characteristics
– Age (years) 67.6 (14.2) 72.1 (13.1) 0.023
– Female sex 89.5 % 100 % –
– Body mass index, kg/m2 25.8 (4.9) 26.5 (6.0) 0.423
– Previous myocardial infarction 4.2 % 8.0 % 0.271
– History of hypertension 63.2 % 68.3 % 0.447
– Diabetes 12.6 % 29.7 % 0.002
– Hyperlipidaemia 36.8 % 64.4 % 0.0001
– Smoking 21 % 26.3 % 0.383
– Family history of CAD 16.8 % 18.2 % 0.806
Concomitant diseases
– Previous stroke 3.2 % 8.9 % 0.097
– History of malignancy 4.2 % 3.0 % 0.651
– COPD 11.6 % 1.0 % 0.002
– Anxiety/depression 8.4 % 6 % 0.515
– Thyroid disorders 23.4 % 11.0 % 0.021
Hypothyroidism 8.5 % 7.0 % 0.694
Hyperthyroidism 10.6 % 3.0 % 0.0335
Goitre in euthyreosis 4.3 % 1.0 % 0.147
Symptoms on admission
– Retrosternal chest pain 83.2 % 96.7 % 0.0015
– Dyspnoea 10.5 % 9.9 % 0.889
– Systolic BP (mmHg) 128.22 (25.99) 133.78 (26.65) 0.141
– Diastolic BP (mmHg) 77.13 (15.29) 82.47 (15.24) 0.015
– Heart rate on admission 83.75 (18.55) 88.10 (17.76) 0.095
– Hearty rate on discharge 69.61 (12.34) 80.92 (18.00) <0.0001
– Sudden cardiac arrest 5.3 % 19.8 % 0.0023
– Pulmonary oedema 6.3 % 14.85 % 0.0535
– Cardiogenic shock 5.3 % 14.85 % 0.0267
– Cardiac arrest, pulmonary oedema, cardiogenic shock 14.7 % 30.7 % 0.0078
Complications
– Pneumonia 20.0 % 35.6 % 0.0148
– Respiratory failure 7.4 % 10.9 % 0.393
– Urinary tract infection 4.2 % 21.8 % 0.0003
– Rhythm disturbances 10.5 % 12.9 % 0.381
Paroxysmal atrial fibrillation 6.3 % 9.9 % 0.357
Ventricular tachycardia 2.1 % 3.0 % 0.690
– AKI/CIAKI 0.0 % 7.9 % 0.0198
AKI 0.0 % 3.96 % 0.0508
CIAKI 0.0 % 3.96 % 0.0508
– Cardiac rupture 3.16 % 1.0 % 0.283
– Stroke 0.0 % 4.95 % 0.0280
– Hospital psychosis 4.2 % 6.9 % 0.411
In-hospital mortality 3.16 % 9.90 % 0.0581
Discharge home 73.7 % 51.5 % 0.0014
Transfer to either hospital, department 23.2 % 40.0 % 0.0116
District hospital 17.9 % 33.7 % 0.0118
Intensive care unit 5.3 % 6.3 % 0.765
Mean hospitalisation time 5.33 (4.41) 5.41 (2.80) 0.879
TTC takotsubo cardiomyopathy, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, BP blood pressure, AKI acute
kidney insufficiency, CIAKI contrast-induced acute kidney insufficiency
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with patients with anterior STEMI (74.52 vs 64.30; p =
0.004) (Table 1, respectively).
In the group with TTC there were more patients with
chronic obstructive pulmonary disease (COPD) (11.6 % vs
1.0 %; p = 0.002) and thyroid disturbances, especially hy-
perthyroidism, as compared with the population with ante-
rior STEMI (23.4 % vs 11.0 %; p = 0.021). Data on comor-
bidities are shown in Table 1.
The main symptom in patients with TTC was retrosternal
pain, but this was less frequent than in the population with
anterior STEMI (83.2 % vs 96.7 %. p = 0.0015). In patients
with TTC, sudden cardiac arrest, pulmonary oedema and
cardiogenic shock were observed less frequently than in
the control group (14.7 % vs 30.7 %; p = 0.0078) (Table 1).
Ischaemic changes on ECG
In 55 % of patients with TTC, ST-segment elevation was
present on admission to hospital, while in almost every
third patient T-wave inversion was recorded. During hospi-
talisation, deep negative T waves were observed in 92 % of
the population with TTC. Also, a significantly prolonged
QTc interval was recorded on the 5th day of hospitalisa-
tion in patients with TTC as compared with patients with
anterior STEMI.
In the population with TTC there were fewer episodes of
atrial fibrillation (5.3 % vs 13.9 %; p = 0.042). Other data
on cardiac arrhythmias and conductibility disturbances are
shown in Table 2.
Coronary angiography
In 44 % of the patients with TTC no atherosclerotic changes
were observed; in the remaining 56 % of the population
changes were insignificant (Table 2).
Echocardiography and ventriculography
In 95 patients typical contractility disturbances with api-
cal involvement on echocardiography and ventriculography
were recorded. We observed transient akinesis of the left
ventricular mid segments without apical involvement in one
patient. Mean left ventricular ejection fraction (LVEF) was
39.8 % and was significantly higher than in patients with
anterior STEMI (35.09 %, p = 0.001). On control echocar-
diography, performed in 30 % of the patients with TTC,
improvement of LVEF was recorded (mean LVEF 48.8 %).
Other echocardiographic and angiographic data are shown
in Table 2.
Cardiac necrotic markers and other laboratory
parameters
Of the patients with TTC, 87.4 % had a significantly raised
concentration of cardiac necrotic markers (troponins) but
the increase in concentration of cardiac markers was lower
than in the population with anterior STEMI (5.32 vs 27.27;
p < 0.0001). The population with TTC had also a lower
white cell count (9.73 vs 12.17; p < 0.0001) and lower con-
centrations of inflammatory parameters such as fibrinogen
(409.53 vs 462.66; p = 0.033). Patients with TTC had lower
glucose concentrations on admission (126.85 vs 180.83;
p < 0.0001) and lower concentrations of total cholesterol
(182.07 vs 209.51; p = 0.0001) and low-density cholesterol
(110.50 vs 140.40; p < 0.0001). Patients with STEMI had
a significantly higher concentration of creatinine and lower
eGFR assessed by the MDRD formula (74.52 vs 64.30; p =
0.004) (Table 2).
Clinical course and complications
Hospitalisation in TTC patients was less frequently com-
plicated by pneumonia (20.0 % vs 35.6 %; p = 0.0148) and
urinary infection (4.2 % vs 21.8 %; p = 0.0003). No cases
of renal failure and strokes were recorded. Cardiac rupture
occurred in three patients with TTC and in one with anterior
STEMI.
The majority of the patients with TTC were discharged
home. The patients from the control group were more fre-
quently transferred to other wards and district hospitals
(17.9 % vs 33.7 %; p = 0.0118). Other data on clinical
course and complications are shown in Table 1.
Data on pharmacological treatment are shown in Table 3.
Early and late prognosis
In-hospital mortality was significantly lower in the group
with TTC. Of three patients who died during hospitalisa-
tion, two had a cardiac rupture and one brain injury after
a long resuscitation. Mortality at 30 days, 3 months, 1 year
and 2.5 years was significantly lower in patients with TTC
than in patients with anterior STEMI (p = 0.035; p = 0.0226;
p = 0.0075; p = 0.009) (Table 1, Fig. 1.).
Discussion
Over 20 years have passed by since TTC was described
by Sato et al. but ‘apical ballooning syndrome’ remains
a poorly defined disease entity when it comes to aetiology
and management.
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Table 2 Electrocardiogram, echocardiography, angiography and laboratory parameters
TTC
n = 95 (SD)
Anterior STEMI
n = 101 (SD)
p
Electrocardiogram
– Rhythm on admission
Sinus rhythm 91.5 % 86.1 % 0.232
Atrial fibrillation 5.3 % 13.9 % 0.042
Pacemaker rhythm 3.2 % 0.0 % 0.084
– Conduction disorders 17.9 % 24.8 % 0.240
LBBB/RBBB 6.3 % 9.92 % 0.355
LBBB 4.2 % 2.0 % 0.372
RBBB 2.1 % 7.92 % 0.064
Left anterior hemiblock 8.4 % 10.9 % 0.554
First-degree atrioventricular block 3.2 % 4.95 % 0.537
– ST elevation 54.7 % 100 % <0.0001
– ST depression 4.2 % 2.0 % 0.372
– T-wave inversion 23.2 % 2.0 % <0.0001
– Deep T-wave inversion (after a few days) 92.2 % 66.3 % <0.0001
– QT on admission (ms) 406.7 (50.08) 395.04 (45.16) 0.156
– QTc on admission (ms) 468.86 (38.66) 465.59 (28.07) 0.561
– QT after a few days 449.72 (57.73) 414.45 (48.48) 0.0002
– QTc after a few days 476.73 (84.49) 469.87 (30.85) 0.494
Echocardiography/ventriculography
– Left ventricular ejection fraction (%)
EF on admission (%) 39.9 (9.9) 35.1 (9.8) 0.001
EF after a few days – mean 4 (%) 48.8 (9.9) – –
– Left ventricular diameter on admission (mm) 47.6 (4.8) 45.8 (5.2) 0.014
– Apical variant of TTC 99 % – –
– Midventricular variant of TTC 1.05 % – –
Coronarography
No atherosclerotic changes in coronary arteries 44.2 % – –
Insignificant stenosis 55.8 % 3.0 %a –
Significant stenosis – 95 %a –
Laboratory parameters
– Haemoglobin (mg/dl) 13.35 (1.63) 13.10 (1.35) 0.236
– Erythrocytes (mln/μl) 4.49 (0.65) 4.40 (3.68) 0.263
– Haematocrit (%) 39.54 (6.13) 39.36 (3.68) 0.808
– Leukocytes (thousands/μl) 9.73 (3.96) 12.17 (4.18) <0.0001
– Platelets (thousands/μl) 245.59 (93.32) 243.73 (76.77) 0.055
– Creatinine (mg/dl) 0.90 (0.37) 1.02 (0.65) 0.121
– eGFR MDRD 74.52 (27.21) 64.30 (22.28) 0.004
– ASAT (IU/l) 48.79 (35.13) 80.01 (107.71) 0.027
– ALAT (IU/l) 31.48 (34.26) 39.94 (55.49) 0.277
– Creatine kinase (IU/l) 435.62 (940.52) 1966.37 (2378.18) <0.0001
– CK-MB (IU/l) 50.15 (72.39) 280.76 (318.5) <0.0001
– Troponin I, mean concentration (ng/ml) 5.32 (11.66) 27.27 (20.98) <0.0001
– Glycaemia on admission (mg/dl) 126.85 (47.35) 180.83 (87.08) <0.0001
– Total cholesterol (mg/dl) 182.07 (41.27) 209.51 (50.14) 0.0001
– Low-density lipoprotein (mg/dl) 110.50 (38.12) 140.40 (46.83) <0.0001
516 Neth Heart J (2016) 24:511–519
Table 2 Electrocardiogram, echocardiography, angiography and laboratory parameters (Continued)
TTC
n = 95 (SD)
Anterior STEMI
n = 101 (SD)
p
– High-density lipoprotein (mg/dl) 52.35 (17.48) 50.21 (17.94) 0.425
– Triglycerides (mg/dl) 98.71 (52.12) 104.65 (68.29) 0.520
– Fibrinogen (mg/dl) 409.53 (160.08) 462.66 (147.90) 0.033
LBBB left bundle branch block, RBBB right bundle branch block, TTC takotsubo cardiomyopathy
aIn two patients with anterior STEMI, coronary angiography was not carried out and they were treated conservatively due to a long delay between
the onset of chest pain and hospital admission
Table 3. Pharmacological treatment and intra-aortic balloon pump (IABP)
TTC (%)
n = 95 (SD)
Anterior STEMI (%)
n = 101 (SD)
p
GP IIb/IIIa inhibitors – 31,7 –
– Abciximab – 12.9 –
– Eptifibatide – 18.8 –
Heparin 91.6 98.0 0.0419
– Unfractionated heparin 36.8 57.4 0.0038
– Enoxaparin 52.6 40.6 0.092
– Fondaparinux 2.1 0.0 0.146
Nitroglycerin 14.7 31.7 0.0051
Clopidogrel 82.1 99 <0.0001
Aspirin 97.9 98.0 0.951
Statins 89.5 86.1 0.477
Beta blockers 87.4 89.1 0.705
ACEI/ARB 89.5 82.2 0.144
ACEI 82.1 79.2 0.608
ARB 7.4 3.0 0.163
Calcium blockers 8.4 5.9 0.501
Diuretics 49.5 70.3 0.0029
Proton pump inhibitors 74.7 90.1 0.0045
Pressor amines 13.7 22.0 0.130
Intra-aortic balloon pump 2.11 7.14 0.097
ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, IABP intra-aortic balloon pump
In recent years, there were about 2,000 patients per year
with MI in the northern-eastern part of Poland (Podlasie
Province, data from general cardiology consultant Profes-
sor G. Opolski). In the years 2008–2012, 95 patients were
diagnosed with TTC in all catheterisation laboratories in
Podlasie Province, which accounts for 1 % of all acute coro-
nary syndromes. Stress cardiomyopathy appears mainly in
middle-aged women (89 % of our study group). In the sim-
ilar group with TTC investigated by Tsuchihashi et al. [13]
86 % were women; the mean age was 67. In other published
data, women account for 80–100 % of the population with
a mean age of 61–76 years [5, 14]. It is worth noting that
TTC may also be diagnosed in younger women. In our
group the youngest female was 15 years old, the oldest was
100 years.
In our population with TTC, similarly to data from the
literature, we observed less cardiovascular risk factors than
in patients with anterior STEMI but more cases of COPD
(11.6 %) and thyroid disturbances (23.4 %), mainly hyper-
thyroidism [5].
Disturbances in thyroid function in patients with TTC
had already been noticed by other investigators. Sarullo
et al. [15] analysed TTC in patients with hyperthyroidism
while Cacciotti et al. [16] found hypothyroidism in 29.3 %
of their patients with stress cardiomyopathy. The associa-
tion between hyperthyroidism and hypothyroidism and TTC
remains unclear, but many investigators suggest focusing on
thyroid function.
In a few papers, COPD was included in the clinical char-
acteristics of the patients with TTC, but only rare single
cases were described in which stress cardiomyopathy was
linked with COPD as provoking factor. Among other pro-
voking factors, asthma, mental and physical strain were
mentioned [13, 17].
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Fig. 1a–d Kaplan-Meier curves showing survival in patients diagnosed with Takotsubo cardiomyopathy and anterior ST-segment elevation
myocardial infarction at 30-day, 3-month, 1-year and 2.5-year follow-up
The main symptom in TTC was retrosternal chest pain
exactly the same as in STEMI. We observed chest pain in
83 % of our patients. In other studies chest pain typical for
MI was observed in 54–100 % of the patients with TTC [5].
In our group with TTC we observed serious complica-
tions, such as cardiogenic shock, pulmonary oedema and
cardiac arrest, significantly less frequently than in patients
with anterior STEMI. These adverse cardiovascular events
occurred in 14.7 % of the patients with TTC. In other pub-
lications cardiogenic shock and pulmonary oedema were
observed more often. According to Tsuchihashi et al. [13]
pulmonary oedema was observed in 22 % of patients with
TTC, and 8 % needed intra-aortic counterpulsation. Sur-
prising data were published by Song et al. [17]. They ob-
served cardiogenic shock in 35 % and pulmonary oedema
in 42 % of their patients with TTC. On the other hand Par-
odi et al. [18] reported cardiogenic shock in 5 % of their
population with TTC.
In our study 3 patients (3.16 %) with TTC had cardiac
rupture, while in the anterior STEMI group in which there is
a high risk of cardiac rupture – only one. In their systematic
analysis, Kumar et al. [9] described 12 cases of cardiac
rupture in patients with TTC. Ten patients out of 12 died.
In the majority of them perforation of the left ventricular
wall was confirmed on autopsy. In our study 2 patients
died. One female with cardiac rupture in the apex of the left
ventricle diagnosed on ventriculography survived thanks to
urgent cardiac surgery.
In-hospital and late mortality were significantly lower
in the group with TTC than in patients with MI. During
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hospitalisation, 3 (3.16 %) patients with TTC died due to
cardiac complications. Exactly the same 3 % in-hospital
mortality due to cardiovascular reasons was reported by
Nunez-Gil et al. [19] and 2 % cardiovascular mortality by
Parodi et al. [18] In some observational studies there were
no deaths in patients with TTC during hospitalisation but
according to other authors mortality is much higher and
even reached 8 % [20]. After 2.5 years, 15.8 % of our study
patients had died. The reasons of death were not connected
with cardiovascular reasons but mainly with cancer. Song
et al. [17] observed 9 % mortality after 5-year follow-up.
The reasons of death were non-cardiac.
TTC is one of the least known cardiac diseases. Al-
though clinical presentation is similar to MI, the prognosis
is much better. Nevertheless it is worth noting that the
course of TTC can be complicated by serious events such
as cardiac rupture, pulmonary oedema, cardiac arrest which
causes substantial early hazard.
Study limitations
Takotsubo cardiomyopathy was diagnosed according to
Mayo Clinic criteria. Of the patients from takotsubo group,
56 % had non-obstructive CAD. We could not exclude
spasm and spontaneous thrombolysis in patients with non-
obstructive CAD.
Conclusions
Previously considered to be a benign syndrome, TTC
should be reconsidered as a clinical condition at risk of
serious complications such as cardiac arrest, cardiogenic
shock, pulmonary oedema and cardiac rupture leading to
death. The TTC population was diagnosed with a signif-
icantly higher rate of COPD and thyroid disorders than
patients with STEMI. Early and late prognosis in patients
with TTC is better than in patients with anterior STEMI.
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